Articles by Angie Drakulich - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Angie Drakulich

Global Healthcare on the Ground: USAID Works to Carry out President Obama's Global Health Initiative

Cultivating a productive investment environment will require partnerships with a range of stakeholders.
Dec 2, 2011

Cultivating a productive investment environment will require partnerships with a range of stakeholders.

Global Healthcare on the Ground: Novartis Focuses on Treating Rare Diseases

Novartis AG and Novartis Pharmaceuticals Corporation have been focusing research efforts on rare diseases since the company was established in 1996.
Nov 2, 2011

Novartis AG and Novartis Pharmaceuticals Corporation have been focusing research efforts on rare diseases since the company was established in 1996.

Is Noncompliance Just Human Nature?

Corporate management must be held accountable for quality at all levels.
Oct 2, 2011

Corporate management must be held accountable for quality at all levels.

Global Healthcare on the Ground: AAPS on Why Global HealthCare is Important Now

AAPS Global Health Focus Group's Kishor M. Wasan discusses new initiatives.
Oct 2, 2011

AAPS Global Health Focus Group's Kishor M. Wasan discusses new initiatives.

FDA and Department of Health Address Drug Shortages

Sep 15, 2011

FDA Commissioner Margaret Hamburg and US Assistant Secretary for Health Howard Koh released a statement aimed at a stakeholder meeting being held at the US Department of Health and Human Services to address the growing issue of drug shortages in the United States.

FDA and Senate Call for Urgent Supply Chain Attention

Deborah Autor testifies before US Senate HELP committee on requested authorities to improve pharma supply chain.
Sep 14, 2011

Deborah Autor testifies before US Senate HELP committee on requested authorities to improve pharma supply chain.

FDA Issues Letter to Pfizer Regarding Violative Online Marketing

Sep 8, 2011

FDA's Division of Drug Marketing, Advertising, and Communication issued a letter to Pfizer's vice-president of US Regulatory Affairs regarding its online resources page for Lipitor tablets.

Atypical Actives Gain Attention

Clarifying GMPs for excipients used as actives.
Sep 1, 2011

Clarifying GMPs for excipients used as actives.

USP and Brazil Partner on Public Health Education

Sep 1, 2011

USP and the Brazilian National Agency of Sanitary Surveillance are teaming up to develop joint education activities for professionals involved in formulating and using pharmacopeial monograph standards in Brazil.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here